Myasthenia Gravis Market Report

Global and Region Myasthenia Gravis Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：151
  • REPORT CODE：GMM886231
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Myasthenia Gravis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Myasthenia Gravismarket, defines the market attractiveness level of Myasthenia Gravis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Myasthenia Gravis industry, describes the types of Myasthenia Gravis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Myasthenia Gravis market and the development prospects and opportunities of Myasthenia Gravis industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Myasthenia Gravis market in Chapter 13.

    By Player:

    • Grifols SA

    • Pfizer

    • RPG Life Sciences

    • AbbVie Inc

    • Novartis Pharmaceuticals Corporation

    • Biogen Inc

    • GlaxoSmithKline

    • F Hoffmann Roche La Ltd

    • Bristol-Myers Squibb Company

    • Valeant Pharmaceuticals International

    By Type:

    • Drug Treatment

    • Rapid Immunotherapies

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Myasthenia Gravis Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Myasthenia Gravis Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Myasthenia Gravis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Myasthenia Gravis Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Myasthenia Gravis Market Analysis and Outlook to 2022

    • 7.1 Global Myasthenia Gravis Consumption (2017-2022)

    • 7.2 United States Myasthenia Gravis Consumption (2017-2022)

    • 7.3 Europe Myasthenia Gravis Consumption (2017-2022)

    • 7.4 China Myasthenia Gravis Consumption (2017-2022)

    • 7.5 Japan Myasthenia Gravis Consumption (2017-2022)

    • 7.6 India Myasthenia Gravis Consumption (2017-2022)

    • 7.7 South Korea Myasthenia Gravis Consumption (2017-2022)

    8 Region and Country-wise Myasthenia Gravis Market Analysis and Outlook to 2028

    • 8.1 Global Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.2 United States Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.3 Europe Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.4 China Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.5 Japan Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.6 India Myasthenia Gravis Consumption Forecast (2022-2028)

    • 8.7 South Korea Myasthenia Gravis Consumption Forecast (2022-2028)

    9 Global Myasthenia Gravis Market Outlook by Types and Applications to 2022

    • 9.1 Global Myasthenia Gravis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Drug Treatment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Rapid Immunotherapies Consumption and Growth Rate (2017-2022)

    • 9.2 Global Myasthenia Gravis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Myasthenia Gravis Market Outlook by Types and Applications to 2028

    • 10.1 Global Myasthenia Gravis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Drug Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Rapid Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Myasthenia Gravis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Myasthenia Gravis Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Myasthenia Gravis Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Myasthenia Gravis Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Myasthenia Gravis Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Myasthenia Gravis Market Competitive Analysis

    • 14.1 Grifols SA

      • 14.1.1 Grifols SA Company Details

      • 14.1.2 Grifols SA Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Grifols SA Myasthenia Gravis Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Myasthenia Gravis Product and Service

    • 14.3 RPG Life Sciences

      • 14.3.1 RPG Life Sciences Company Details

      • 14.3.2 RPG Life Sciences Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 RPG Life Sciences Myasthenia Gravis Product and Service

    • 14.4 AbbVie Inc

      • 14.4.1 AbbVie Inc Company Details

      • 14.4.2 AbbVie Inc Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AbbVie Inc Myasthenia Gravis Product and Service

    • 14.5 Novartis Pharmaceuticals Corporation

      • 14.5.1 Novartis Pharmaceuticals Corporation Company Details

      • 14.5.2 Novartis Pharmaceuticals Corporation Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis Pharmaceuticals Corporation Myasthenia Gravis Product and Service

    • 14.6 Biogen Inc

      • 14.6.1 Biogen Inc Company Details

      • 14.6.2 Biogen Inc Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Biogen Inc Myasthenia Gravis Product and Service

    • 14.7 GlaxoSmithKline

      • 14.7.1 GlaxoSmithKline Company Details

      • 14.7.2 GlaxoSmithKline Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Myasthenia Gravis Product and Service

    • 14.8 F Hoffmann Roche La Ltd

      • 14.8.1 F Hoffmann Roche La Ltd Company Details

      • 14.8.2 F Hoffmann Roche La Ltd Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann Roche La Ltd Myasthenia Gravis Product and Service

    • 14.9 Bristol-Myers Squibb Company

      • 14.9.1 Bristol-Myers Squibb Company Company Details

      • 14.9.2 Bristol-Myers Squibb Company Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Company Myasthenia Gravis Product and Service

    • 14.10 Valeant Pharmaceuticals International

      • 14.10.1 Valeant Pharmaceuticals International Company Details

      • 14.10.2 Valeant Pharmaceuticals International Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Valeant Pharmaceuticals International Myasthenia Gravis Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Myasthenia Gravis

    • Figure Myasthenia Gravis Picture

    • Table Global Myasthenia Gravis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Myasthenia Gravis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Myasthenia Gravis Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Myasthenia Gravis Consumption by Country (2017-2022)

    • Figure United States Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Table Europe Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure China Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Japan Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure India Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Myasthenia Gravis Consumption and Growth Rate (2017-2022)

    • Figure Global Myasthenia Gravis Consumption Forecast by Country (2022-2028)

    • Figure United States Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Myasthenia Gravis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rapid Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Myasthenia Gravis Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Myasthenia Gravis Export by Region (Top 5 Countries) (2017-2028)

    • Table Grifols SA (Foundation Year, Company Profile and etc.)

    • Table Grifols SA Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols SA Myasthenia Gravis Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Myasthenia Gravis Product and Service

    • Table RPG Life Sciences (Foundation Year, Company Profile and etc.)

    • Table RPG Life Sciences Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table RPG Life Sciences Myasthenia Gravis Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Myasthenia Gravis Product and Service

    • Table Novartis Pharmaceuticals Corporation (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharmaceuticals Corporation Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmaceuticals Corporation Myasthenia Gravis Product and Service

    • Table Biogen Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen Inc Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Inc Myasthenia Gravis Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Myasthenia Gravis Product and Service

    • Table F Hoffmann Roche La Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann Roche La Ltd Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann Roche La Ltd Myasthenia Gravis Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Myasthenia Gravis Product and Service

    • Table Valeant Pharmaceuticals International (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals International Myasthenia Gravis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals International Myasthenia Gravis Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US